Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2005
11/16/2005EP1594499A1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha
11/16/2005EP1476429B1 Novel pyridine- and quinoline-derivatives
11/16/2005EP1463823A4 Methods of increasing endogenous erythropoietin (epo)
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1363608B1 Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleep disturbances
11/16/2005EP1331919A4 Dental composition for hypersensitive teeth
11/16/2005EP1248768B1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005EP1146857B1 Materials and methods for making improved micelle compositions
11/16/2005EP1114052B1 4-aminopyrrolopyrimidines as kinase inhibitors
11/16/2005EP0904099B1 Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005CN1697836A Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/16/2005CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227261C Monocyclic compounds with four bifunctional residues having NK-2 antagonist action, its preparation, medicine compositions and uses
11/16/2005CN1227251C Carbamates derived from arylalkylamines
11/16/2005CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
11/16/2005CN1227246C Improved omeprazole preparation process and compositions thereof
11/16/2005CN1227241C Arylpiperazines having activity at the serotnin 1A receptor
11/16/2005CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
11/16/2005CN1227033C Method of treating cancer with anti-neurotrophin agents
11/16/2005CN1227021C Capsule with high cellulose for expelling of toxin and nourishing skin as well as its manufacturing methods
11/16/2005CN1227020C Nourishing health Chinese medicine for students
11/16/2005CN1227019C Chinese medicine preparation for preventing fibrillated liver and treating hepatocirrhosis
11/16/2005CN1227009C Pharmaceutical composition containing porton pump inhibitors
11/16/2005CN1226934C Health-care tea
11/15/2005US6965027 Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate
11/15/2005US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6964984 Preventing desensitization of receptors
11/15/2005US6964981 Therapeutic treatment or prevention of physiological disorders associated with an excess of tachykinins, with neurokinin 1 (NK-1) receptor antagonists; a 2-phenyl-2-(3-phenyl-tetrahydrofuran-2-yloxy)- ethanol
11/15/2005US6964979 Liver disorders
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/15/2005CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2111512C 3,5-substituted aminobenzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005105119A1 5-aminosalicylic acid of slow-released type in magnetic intercalated structure and the preparation method thereof
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury
11/10/2005US20050250825 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis
11/10/2005US20050250802 Novel substituted amines of spirofuropyridines useful in therapy
11/10/2005US20050250796 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives
11/10/2005US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
11/10/2005US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250693 Metalloproteinase inhibitors
11/10/2005US20050250679 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
11/10/2005US20050250203 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050249783 Method of improving absorption of vitamin e by a pet animal
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249670 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
11/10/2005CA2564521A1 Epitopes related to coeliac disease
11/09/2005EP1593666A1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593382A1 Use of probiotic lactic bacteria for balancing the skin's immune system
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1593378A1 Remedy for viral disease
11/09/2005EP1593375A1 Body cavity washer, device for washing body cavity and method of washing body cavity
11/09/2005EP1592774A1 Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1419163B9 Tricyclic imidazopyridines
11/09/2005EP1416953A4 Methods of treating liver fibrosis
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1261259B1 Treatment of infection in animals
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1220932B1 Human carboxypeptidases and polynucleotides encoding the same
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1173218B1 Mucosally adhesive compositions for the treatment of disorders of the oesophagus and their use.
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1075519B1 Inhibitors of nf-kb activation
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005CN1695059A Method of diagnosing colon and gastric cancers
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694898A HBV precore protein capable of forming particles
1 ... 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 ... 1258